News & Media

PressDECEMBER 4, 2025

Mission Bio Announces Results Leveraging Tapestri Single Cell Multi-Omics Platform for Exploratory Biomarker Analysis in Myeloproliferative Neoplasms (MPNs) to be Presented at ASH 2025

PressNOVEMBER 20, 2025

Mission Bio Announces Single-Cell Targeted DNA + RNA Assay at ASH 2025, Closing the Mutation-to-Expression Gap in Cancer Research

PressOCTOBER 9, 2025

Mission Bio Appoints Dr. Zivjena Vucetic as Chief Medical Officer to Lead Clinical Adoption and Biopharma Partnerships

PressAUGUST 5, 2025

Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion

PressJUNE 5, 2025

Mission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution Aimed at Derisking Cancer Drug Clinical Development

PressMAY 21, 2025

Nature Publication Shows Mission Bio's Tapestri® Platform Enables Real-Time, Single-Cell Tracking of Precancerous Clones Using Natural Epigenetic Markers

NewsMAY 7, 2025

Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis

NewsMAY 7, 2025

Mission Bio, IDT Partner on Sequencing-Based Genome Editing Validation

PressMAY 6, 2025

Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis

PressDECEMBER 5, 2024

Mission Bio Showcases Critical Insights Into Multiple Myeloma, AML MRD, CAR-T Safety & Integrated Single-Cell DNA and Fusion Profiling at the 2024 ASH Annual Meeting

PressDECEMBER 2, 2024

Mission Bio Partners With Top Researchers From University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma Patients

PressSEPTEMBER 26, 2024

Mission Bio Launches Innovative Single-cell Genome Integrity Solution to Measure Whole Genome Copy Number Variation in Advanced Therapies and Tumor Samples

NewsAUGUST 21, 2024

Detecting Translocations in Gene Edited Cells

NewsAUGUST 21, 2024

Using Single Cell Sequencing for Gene Editing Quality Control

PressAUGUST 20, 2024

Mission Bio’s Tapestri Platform Utilized in Development of Advancements in Gene-Edited T-Cell Therapy

PressJULY 11, 2024

Mission Bio Appoints Roman Haehn as Chief Commercial Officer to Drive Market Expansion

NewsJUNE 4, 2024

Mission Bio Launches First-Ever Single-Cell Multiomics Test for Myeloma Research

NewsJUNE 4, 2024

An Interview with Brian Kim

PressJUNE 4, 2024

Mission Bio Announces Launch of First Single-Cell Multiple Myeloma Multiomics Solution Aimed to Transform Translational Research and Therapy Development

NewsMAY 14, 2024

Single-Cell Multiomics Is Advancing Cancer Research